Recent

% | $
Quotes you view appear here for quick access.

Seattle Genetics, Inc. Message Board

Title   Replies Latest Post

Just like clock work

Apr 15, 2015 2:51 PM by fstout57
0/2 1 Apr 17, 2015 3:31 PM by fstout57

Big selloff here

Apr 17, 2015 10:05 AM by fstout57
0/5 3 Apr 17, 2015 12:00 PM by fstout57

April 30th

Apr 15, 2015 11:30 PM by llabtechtwo
2/0 8 Apr 17, 2015 11:42 AM by koolbrez22

Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate o...

Apr 16, 2015 12:38 PM by w1nner123
3/0 1 Apr 17, 2015 11:38 AM by koolbrez22

Non Adcetris ADCs - Finally

Apr 16, 2015 4:02 PM by paladin_roams
3/1 1 Apr 16, 2015 4:09 PM by w1nner123

Brentuximab Vedotin Plus AVD in Limited-stage Hodgkin Lymphoma - Phase 2

Apr 16, 2015 12:41 PM by w1nner123
3/0 2 Apr 16, 2015 3:30 PM by fstout57

anybody else in ADXS and enjoying the run? Any thoughts on it?

Apr 13, 2015 2:05 PM by wsucougarsgrad
1/0 3 Apr 16, 2015 10:46 AM by fstout57

After hrs.

Apr 16, 2015 1:17 AM by fstout57
0/1 0 Apr 16, 2015 1:17 AM by fstout57

Technicaly, the bottom is in and

Apr 7, 2015 10:41 AM by renmanaz
2/0 17 Apr 15, 2015 11:19 PM by fstout57

wow

Apr 15, 2015 9:36 AM by fstout57
0/1 4 Apr 15, 2015 12:13 PM by fstout57

Very significant

Apr 12, 2015 8:38 PM by hmoffsuite
4/0 0 Apr 12, 2015 8:38 PM by hmoffsuite

Anyone click on Edgar Online Financials

Apr 7, 2015 3:04 PM by fstout57
0/5 0 Apr 7, 2015 3:04 PM by fstout57

The AETHERA label indication was added to the NCCN Guidelines for Hodgkin Lymphoma today.

Apr 6, 2015 9:42 PM by w1nner123
7/0 1 Apr 7, 2015 12:38 PM by w1nner123

Positive news for SGEN & CLDX collaboration for Glembatumumab vedotin tx for breast ca...

Apr 7, 2015 12:36 PM by w1nner123
2/0 0 Apr 7, 2015 12:36 PM by w1nner123

Annual meeting 5/15/2015

Apr 6, 2015 4:59 PM by dpemco
0/0 0 Apr 6, 2015 4:59 PM by dpemco

Help Us Make it Better!

We are in the process of testing our new message boards.
Please provide your feedback so that we can optimize the user experience.

Go
Must Watch
SGEN
47.65-0.17(-0.36%)Jul 2 4:00 PMEDT